For his final "Executive Decision" segment of Mad Money Wednesday evening, Jim Cramer checked in Kevin Conroy, president, chairman and CEO of EXACT Sciences Corp. (EXAS) , makers of Cologuard, the colon cancer screening test that replaces traditional colonoscopies for some people.
Conroy said that cancer remains the second largest killer in our country, claiming 600,000 people a year. Yet despite those numbers, most people are still not tested for most cancers. That's why the early data from their multi-cancer screening test is so important. It can detect up to six cancers 84% of the time with very low false-positive rates.
Exact Sciences is also active in Covid-19 testing. Conroy said his company has tested hundreds of thousands of people in all 50 states and he couldn't be more proud of his team and the diagnostic industry which is stepping up to help their communities.